NRX Pharmaceuticals Inc
NRXP
Get informed when a big investor buys or sells
+ FollowMarket Cap$54.45M
Close$
$0.57
82.3% downside
Current Fair Value
82.3% downsideOvervalued by 82.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $54.45 Million |
|---|---|
| Enterprise Value | $48.67 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.34 |
| Beta | 2.19 |
| Outstanding Shares | 32,325,323 |
Return
| Return on Equity | 177.63% |
|---|---|
| Return on Assets | -206.17% |
| Return on Invested Capital | 247.17% |
Valuation & Multiples
| P/E Ratio | -2.46 |
|---|---|
| PEG | 3.32 |
| Price to Sales | - |
| Price to Book Ratio | -3.24 |
| Enterprise Value to Revenue | 21.23 |
| Enterprise Value to EBIT | -1.48 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | -0.07 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 21, 2026
EPS Estimate
$-0.05
Average shareholder expectationRevenue Estimate
$25.57 M
Average shareholder expectationNext Earnings Call
Expected Date
August 17, 2026
EPS Estimate
$-0.09
Average shareholder expectationRevenue Estimate
$1.33 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.0068▲ 100.68% |
|---|---|
| Total Calls | 131,500▲ 39.60% |
| Total Puts | 132,400▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 19.20%▲ 2.70% |
|---|---|
| Total Invested | $13.25M▼ 6.52% |
| Investors Holding | 38▲ 7.00% |
ESG Score
No data
About NRX Pharmaceuticals Inc
2 employeesBig Rock Partners is a blank check company formed for the purpose of entering into a merger, stock exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more busi...